We demonstrated in vitro and in vivo that C-terminal terminus of MSI1 could work as a decoy to disrupt the endogenous MSI1/AGO2 interaction, and to efficiently block the oncogenic functions of the endogenous MSI1/AGO2 complex as well as inhibit xenograft tumor growth (Figure 7). The gene discussed is MSI1; the disease is neoplasm.